Inactive Instrument

Highlights Pangaea Oncology, S.A. BME

Equities

Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	05-08	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	30/10/23	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	27/10/22	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	28/10/21	CI
Vidaro Inversiones S.L. acquired 6.62% stake in Pangaea Oncology, S.A. from HERSOL XXI, SL for €1.5 million.	12/10/20	CI
HERSOL XXI, SL acquired an additional 0.6% stake in Pangaea Oncology, S.A. from director of Grupo Pikolin, S.L. for €0.15 million.	02/01/18	CI
GrupoPikolin, S.L. acquired 24.94% stake in Pangaea Oncology, S.A. from Mercantile Ebrosol Inversiones, S.L.U.	02/01/17	CI

No results for this search